Clinical Trial

The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this clinical trial is to learn if the drug guarana improves symptoms of fatigue in patients with neuroendocrine tumors and gynecologic cancers
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-28; most recent amendment 2026-02-05.
Status change: Not Yet Recruiting → Recruiting 2025-09-03
Trial Details
NCT Number NCT07151391
Lead Sponsor University of Utah
Conditions Neuroendocrine Tumors, Gynecologic Cancer
Enrollment 86 participants
Start Date 2025-09-03
Primary Completion 2027-09 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-07